Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer

Phytomedicine

Volumn 22, Issue 10, 2015, Pages 961-967

  Zamani, Mina ^a   Sadeghizadeh, Majid ^a   Behmanesh, Mehrdad ^a   Najafi, Farhood ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b INSTITUTE FOR COLOR SCIENCE AND TECHNOLOGY   (Iran)

Author keywords

Dendrosomal curcumin; DNA methylation; Epigenetic therapy; Hepatocellular cancer; Long non coding RNA; miRNA

Indexed keywords

CURCUMIN; DENDROSOMAL CURCUMIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; LONG UNTRANSLATED RNA; MATERNALLY EXPRESSED GENE 3; MICRORNA; MICRORNA 185; MICRORNA 29A; NANOCARRIER; PROTEIN P53; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; MEG3 NON-CODING RNA, HUMAN; MIRN29 MICRORNA, HUMAN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; MTT ASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UPREGULATION; CHEMISTRY; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CURCUMIN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROMOTER REGIONS, GENETIC; RNA, LONG NONCODING; UP-REGULATION;

EID: 84939176791     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2015.05.071     Document Type: Article

References (28)

1. Alizadeh A.M., Khaniki M., Azizian S., Mohaghgheghi M.A., Sadeghizadeh M., Najafi F. Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier - curcumin Eur. J. Pharmacol 689 2012 226 232
2. Amaral P.P., Mattick J.S. Noncoding RNA in development Mamm. Genome 19 2008 454 492
3. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
4. Babaei E., Sadeghizadeh M., Hassan Z.M., Feizi M.A., Najafi F., Hashemi S.M. Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo Int. Immunopharmacol. 12 2012 226 234
5. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., Maitra A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy J. Nanobiotechnol. 5 2007 3
6. Braconi C., Kogure T., Valeri N., Huang N., Nuovo G., Costinean S., Negrini M., Miotto E., Croce C.M., Patel T. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer Oncogene 30 2011 4750 4756
7. Cheng A.S., Lau S.S., Chen Y., Kondo Y., Li M.S., Feng H., Ching A.K., Cheung K.F., Wong H.K., Tong J.H. et al. EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis Cancer Res. 71 2011 4028 4039
8. Croce C.M. Causes and consequences of microRNA dysregulation in cancer Nat. Rev. Genet. 10 2009 704 714
9. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C. et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc. Natl. Acad. Sci. USA 104 2007 15805 15810
10. Fraga M.F., Esteller M. DNA methylation: a profile of methods and applications Biotechniques 33 2002 632 634, 636-649
11. Garzon R., Liu S., Fabbri M., Liu Z., Heaphy C.E., Callegari E., Schwind S., Pang J., Yu J., Muthusamy N. et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 Blood 113 2009 6411 6418
12. Geng Y.J., Xie S.L., Li Q., Ma J., Wang G.Y. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression J. Int. Med. Res. 39 2011 2119 2128
13. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas Mol. Cancer 10 2011 38
14. Malich G., Markovic B., Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines Toxicology 124 1997 179 192
15. Meeran S.M., Ahmed A., Tollefsbol T.O. Epigenetic targets of bioactive dietary components for cancer prevention and therapy Clin. Epigenet. 1 2010 101 116
16. Reuter S., Gupta S.C., Park B., Goel A., Aggarwal B.B. Epigenetic changes induced by curcumin and other natural compounds Genes Nutr. 6 2011 93 108
17. Sadeghizadeh M., Ranjbar B., Damaghi M., Khaki L., Sarbolouki M.N., Najafi F., Parsaee S., Ziaee A.-A., Massumi M., Lubitz W. et al. Dendrosomes as novel gene porters-III J. Chem. Technol. Biotechnol. 6 2008 912 920
18. Sarbolouki M.N., Sadeghizadeh M., Yaghoobi M.M., Karami A., Lohrasbi T. Dendrosomes: a novel family of vehicles for transfection and therapy J. Chem. Technol. Biotechnol. 10 2000 919 922
19. Sawan C., Vaissiere T., Murr R., Herceg Z. Epigenetic drivers and genetic passengers on the road to cancer Mutat. Res. 642 2008 1 13
20. Tahmasebi Mirgani M., Isacchi B., Sadeghizadeh M., Marra F., Bilia A.R., Mowla S.J., Najafi F., Babaei E. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells Int. J. Nanomed. 9 2014 403 417
21. Vikhanskaya F., Lee M.K., Mazzoletti M., Broggini M., Sabapathy K. Cancer-derived p53 mutants suppress p53-target gene expression - potential mechanism for gain of function of mutant p53 Nucleic Acids Res. 35 2007 2093 2104
22. Xiang Y., Ma N., Wang D., Zhang Y., Zhou J., Wu G., Zhao R., Huang H., Wang X., Qiao Y., Li F., Han D., Wang L., Zhang G., Gao X. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine Oncogene 33 2013 378 386
23. Xiong Y., Fang J.H., Yun J.P., Yang J., Zhang Y., Jia W.H., Zhuang S.M. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma Hepatology 51 2010 836 845
24. Yao Z., Mishra L. Cancer stem cells and hepatocellular carcinoma Cancer Biol. Ther. 8 2009 1691 1698
25. Yoo C.B., Jones P.A. Epigenetic therapy of cancer: past, present and future Nat. Rev. Drug Discov. 5 2006 37 50
26. Zhang X., Rice K., Wang Y., Chen W., Zhong Y., Nakayama Y., Zhou Y., Klibanski A. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions Endocrinology 151 2010 939 947
27. Zhang Z., Tang H., Wang Z., Zhang B., Liu W., Lu H., Xiao L., Liu X., Wang R., Li X. et al. MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma Mol. Cancer 10 2011 124
28. Zhao J., Dahle D., Zhou Y., Zhang X., Klibanski A. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors J. Clin. Endocrinol. Metab. 90 2005 2179 2186